PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing significant unmet needs in ulcerative colitis (UC) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback